Mineralys Therapeutics, Inc. (MLYS) has 12 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 Slingsby Brian Taylor 8,903,838 주 보유. 기타 주요 보유자에는 RA CAPITAL MANAGEMENT, L.P. 및 Samsara BioCapital GP, LLC.
지난 12개월간 내부자는 37 건의 거래를 수행 MLYS 주식 — 13 건 매수 (평가액 $19.01M) 및 10 건 매도 (평가액 $1.81M). 내부자 매수가 매도를 초과하여 회사 전망에 대한 자신감의 신호일 수 있습니다.
MLYS 내부자 보유 현황
최대 보유자
Slingsby Brian Taylor
8,903,838 주
내부자 주요 보유자
| # |
이름 |
직책 |
보유 주식수 |
최종 신고일 |
상대적 규모 |
| 1 |
Slingsby Brian Taylor |
10 Percent Owner |
8,903,838 |
2025-04-25 |
|
| 2 |
Ra Capital Management, L.p. |
Director |
5,767,221 |
2026-03-31 |
|
| 3 |
Samsara Biocapital Gp, Llc |
10 Percent Owner |
5,674,916 |
2025-03-17 |
|
| 4 |
Congleton Jon |
Chief Executive Officer |
705,051 |
2026-04-02 |
|
| 5 |
Levy Adam Scott |
CFO and Secretary |
48,538 |
2026-02-20 |
|
| 6 |
Litzka Olivier |
Director |
22,000 |
2024-05-23 |
|
| 7 |
Gold Alexander M |
Director |
6,200 |
2026-02-20 |
|
| 8 |
Akkaraju Srinivas |
10 Percent Owner |
6,200 |
2026-02-20 |
|
| 9 |
Dirocco Derek |
Director |
6,200 |
2026-02-20 |
|
| 10 |
Sblendorio Glenn |
Director |
6,200 |
2026-02-20 |
|
| 11 |
Karydas Daphne |
Director |
6,200 |
2026-04-02 |
|
| 12 |
Rodman David Malcom |
Chief Medical Officer |
5,000 |
2026-03-17 |
|
최근 거래 (최근 12개월)
| 날짜 |
이름 |
직책 |
유형 |
주식수 |
주가 |
금액 |
| 2026-03-31 |
Karydas Daphne |
Director |
정보 매도 |
3,000 |
$25.00 |
$75K |
| 2026-03-31 |
Congleton Jon |
Chief Executive Officer |
정보 매도 |
453 |
$27.05 |
$12.25K |
| 2026-03-30 |
Ra Capital Management, L.p. |
Director |
정보 매수 |
58,300 |
$24.16 |
$1.41M |
| 2026-03-27 |
Ra Capital Management, L.p. |
Director |
정보 매수 |
310,700 |
$23.67 |
$7.35M |
| 2026-03-17 |
Rodman David Malcom |
Chief Medical Officer |
옵션 행사 (매도) |
417 |
$15.44 |
$6.44K |
| 2026-03-13 |
Rodman David Malcom |
Chief Medical Officer |
정보 매도 |
253 |
$27.82 |
$7.04K |
| 2026-03-12 |
Rodman David Malcom |
Chief Medical Officer |
옵션 행사 (매도) |
6,348 |
$1.08 |
$6.86K |
| 2026-03-09 |
Rodman David Malcom |
Chief Medical Officer |
옵션 행사 (매도) |
2,171 |
$16.00 |
$34.74K |
| 2026-03-04 |
Warren Eric |
Chief Commercial Officer |
알 수 없음 |
357,000 |
$13.24 |
$4.73M |
| 2026-02-19 |
Gold Alexander M |
Director |
RSU 부여 |
6,200 |
- |
- |
| 2026-02-19 |
Slingsby Brian Taylor |
10 Percent Owner |
기타 (매도) |
6,200 |
- |
- |
| 2026-02-19 |
Karydas Daphne |
Director |
RSU 부여 |
6,200 |
- |
- |
| 2026-02-19 |
Dirocco Derek |
Director |
RSU 부여 |
6,200 |
- |
- |
| 2026-02-19 |
Levy Adam Scott |
CFO and Secretary |
RSU 부여 |
39,900 |
- |
- |
| 2026-02-19 |
Rodman David Malcom |
Chief Medical Officer |
RSU 부여 |
51,300 |
$28.06 |
$1.44M |
| 2026-02-19 |
Congleton Jon |
Chief Executive Officer |
RSU 부여 |
187,900 |
$28.06 |
$5.27M |
| 2026-02-19 |
Ra Capital Management, L.p. |
Director |
RSU 부여 |
6,200 |
- |
- |
| 2026-02-19 |
Sblendorio Glenn |
Director |
RSU 부여 |
6,200 |
- |
- |
| 2026-02-19 |
Akkaraju Srinivas |
10 Percent Owner |
RSU 부여 |
6,200 |
- |
- |
| 2026-02-17 |
Rodman David Malcom |
Chief Medical Officer |
옵션 행사 (매도) |
417 |
$15.44 |
$6.44K |
| 2026-02-13 |
Rodman David Malcom |
Chief Medical Officer |
정보 매도 |
6,348 |
$27.58 |
$175.1K |
| 2026-02-12 |
Rodman David Malcom |
Chief Medical Officer |
옵션 행사 (매도) |
6,349 |
$1.08 |
$6.86K |
| 2026-02-09 |
Rodman David Malcom |
Chief Medical Officer |
옵션 행사 (매도) |
2,171 |
$16.00 |
$34.74K |
| 2026-01-20 |
Rodman David Malcom |
Chief Medical Officer |
옵션 행사 (매도) |
416 |
$15.44 |
$6.42K |
| 2026-01-14 |
Rodman David Malcom |
Chief Medical Officer |
정보 매도 |
11,367 |
$32.61 |
$370.64K |